The effect of live music on decreasing anxiety in patients undergoing chemotherapy treatment.
The purpose of this study was to investigate the effects of familiar live music on the anxiety levels of patients undergoing chemotherapy treatment. Randomly selected patients were assigned to experimental (n = 25) and control (n = 25) conditions. Pre and posttests consisted of questionnaires and the recording of the patient's heart rate and blood pressures. Subjects in the experimental group received 20 minutes of familiar live music during their chemotherapy treatment. Subjects in the control group received standard chemotherapy. It was assumed that those patients receiving music intervention would: (a) lower their anxiety levels; (b) experience a decrease in heart rate and blood pressure; (c) improve their levels of negative reactions including fatigue, worry, and fear; and (d) improve their levels of positive reactions including comfort and relaxation. Results of the study showed statistically significant improvement for the experimental group on the measures of anxiety, fear, fatigue, relaxation, and diastolic blood pressure. No significant differences between groups were found for heart rate and systolic blood pressure. Descriptive values indicated that, on average, the experimental group was influenced positively by the music intervention, and participants improved their quality of life while undergoing chemotherapy treatment.
Ferrer
Alejandra J
AJ
The Florida State University, Tallahassee Memorial HealthCare, USA.
D000970:Antineoplastic Agents / Q000009:adverse effects; D001007:Anxiety / Q000209:etiology / Q000517:prevention & control*; D005221:Fatigue / Q000209:etiology / Q000517:prevention & control; D005239:Fear; D005260:Female; D006801:Humans; D008297:Male; D009147:Music Therapy / Q000379:methods*; D009369:Neoplasms / Q000188:drug therapy* / Q000523:psychology*; D012064:Relaxation Therapy; D013315:Stress, Psychological / Q000209:etiology / Q000517:prevention & control*; D011795:Surveys and Questionnaires
D000970:Antineoplastic Agents